FertiliFit

Company Overview

Snapshot

Founded in January 2022 by Michal Jacob, FertiliFit operates with 1–10 employees. The company has secured funding across one round from one investor. In January 2023, FertiliFit received a grant from the Israel Innovation Authority.

Business overview

FertiliFit is a Health Tech & Life Sciences company focused on improving the success rates of fertility treatments. The company leverages big data and machine learning algorithms to personalize treatment plans for individual women, aiming to reduce the number of required treatments to achieve a healthy birth. FertiliFit operates within the Digital Healthcare sector, specifically in Medical Decision Support, and targets the Healthcare & Life Sciences industry, serving healthcare providers.

Strategic signal

In July 2023, FertiliFit was highlighted by CTech for its innovative use of AI to provide personalized IVF treatment. This recognition signals the company's potential to disrupt the fertility treatment market by offering data-driven solutions that could enhance patient outcomes and streamline treatment processes, attracting attention from investors and innovation teams seeking advancements in digital healthcare.

Company Intelligence Q&A

When was FertiliFit founded?

FertiliFit was founded in January 2022 by Michal Jacob.

What is FertiliFit's primary mission?

FertiliFit's mission is to increase the probability of success of fertility treatments by adjusting treatment plans to individual women using big data and machine learning algorithms, aiming to decrease the number of required treatments.

Has FertiliFit received any grants?

In January 2023, FertiliFit secured a grant from the Israel Innovation Authority.

What technology does FertiliFit utilize?

FertiliFit utilizes artificial intelligence, specifically machine learning, to personalize IVF treatments.

What was a key media mention for FertiliFit?

In July 2023, CTech featured FertiliFit for its approach to leveraging AI in personalized IVF treatment.